Cedars-Sinai Cancer at Beverly Hills (THO) — Beverly Hills, California

Cedars-Sinai Cancer at Beverly Hills (THO) is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Cedars-Sinai Cancer at Beverly Hills (THO) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Oropharyngeal Cancer, Carcinoma, Non Small Cell Lung Cancer.

Sponsors: Zachary Zumsteg, Karen Reckamp, MD, MS.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedars-Sinai Cancer at Beverly Hills (THO)?

Cedars-Sinai Cancer at Beverly Hills (THO) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedars-Sinai Cancer at Beverly Hills (THO) conducted?

Cedars-Sinai Cancer at Beverly Hills (THO) has 2 clinical trials on record, with 2 currently active. Their work covers Oropharyngeal Cancer, Carcinoma, Non Small Cell Lung Cancer.

Is Cedars-Sinai Cancer at Beverly Hills (THO) accredited by Crixeo Health?

Cedars-Sinai Cancer at Beverly Hills (THO) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedars-Sinai Cancer at Beverly Hills (THO)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.